Clinical Trial Update: Intravenous Streptokinase in Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous streptokinase for acute myocardial infarction has completed enrollment; final results are pending.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Streptokinase (streptokinase)

Snippet

Sponsor: University of Washington | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED